Albemarle has increased its revenue expectations for the year from $9.8 – $11.5 billion to $10.4 – $11.5 billion, primarily citing an expectation for increased lithium chemical and spodumene prices in the third quarter as well as increased volumes through mine expansion and further asset acquisition. This would represent a gain of between 40% and 55% on revenue seen in 2022 which reached $7.2 billion. Albemarle has shifted 80% of its offtake agreements to index-referenced variable price contracts with the remaining 20% still based on spot pricing. The move towards index-based contracts indicates a willingness to be more beholden to current market prices, showing faith that lithium prices will remain elevated for the duration of its contracts which mostly go…